Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.94B
Market cap18.94B
Price-Earnings ratio
24.39
Price-Earnings ratio24.39
Dividend yield
1.02%
Dividend yield1.02%
Average volume
2.20M
Average volume2.20M
High today
$94.25
High today$94.25
Low today
$91.07
Low today$91.07
Open price
$92.75
Open price$92.75
Volume
2.69M
Volume2.69M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $93.93, with a market capitalization of 18.94B. The stock trades at a price-to-earnings (P/E) ratio of 24.39 and offers a dividend yield of 1.02%.

During the trading session on 2026-08-02, Zimmer Biomet(ZBH) shares reached a daily high of $94.25 and a low of $91.07. At a current price of $93.93, the stock is +3.1% higher than the low and still -0.3% under the high.

Trading volume for Zimmer Biomet(ZBH) stock has reached 2.69M, versus its average volume of 2.2M.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

ZBH News

MarketWatch 2d
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Seeking Alpha 5d
Zimmer upgraded to Buy from Sell at UBS on growth and innovation

Zimmer Biomet (ZBH) traded higher on Tuesday after UBS analyst Patrick Wood assumed its coverage and upgraded the stock to Buy from Sell, citing the orthopedic...

Zimmer upgraded to Buy from Sell at UBS on growth and innovation

Analyst ratings

72%

of 29 ratings
Buy
27.6%
Hold
72.4%
Sell
0%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.